Hector Vega

Entos Pharmaceuticals

SCHOLARLY PAPERS

2

DOWNLOADS

299

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Safe and Effective Delivery of Nucleic Acids Using Proteolipid Vehicles Formulated with Fusion-Associated Small Transmembrane Proteins

Number of pages: 66 Posted: 07 Oct 2022
Douglas W. Brown, Ping Wee, Prakash Bhandari, Hector Vega, Liliya Grin, Deborah Sosnowski, Maryam Hejazi, Jailal Ablack, Eileen K. Clancy, Desmond Pink, Jitendra Kumar, Paola Solis Ares, Suellen Lamb, Nichole McMullen, Duncan MacKenzie, Perrin H. Beatty, Henry Garcia, Manoj Parmar, Jennifer Gyoba, Matthew Scholz, Roy Duncan, Arun Raturi and John D. Lewis
University of Alberta - Department of Oncology, Entos Pharmaceuticals, Entos Pharmaceuticals, Entos Pharmaceuticals, Entos Pharmaceuticals, University of Alberta - Department of Oncology, University of Alberta - Department of Oncology, OncoSenX, Dalhousie University - Department of Microbiology & Immunology, University of Alberta - Department of Oncology, Entos Pharmaceuticals, Entos Pharmaceuticals, University of Alberta - Department of Oncology, Dalhousie University - Department of Microbiology & Immunology, Dalhousie University - Department of Microbiology & Immunology, Entos Pharmaceuticals, Oisin Biotechnologies, Entos Pharmaceuticals, Entos Pharmaceuticals, Oisin Biotechnologies, Dalhousie University - Department of Microbiology & Immunology, Entos Pharmaceuticals and University of Alberta - Department of Oncology
Downloads 189 (345,401)

Abstract:

Loading...

Encapsulation, FAST proteins, FAST-PLV, Gene therapy, Nucleic acid delivery, proteolipid vehicle, PLV, p14endo15, Follistatin

2.

Immunogenicity of a SARS-CoV-2 DNA Vaccine Formulated With the Fusion-Associated Small Transmembrane Protein Proteolipid Vehicle Delivery System

Number of pages: 49 Posted: 01 Nov 2022
Arun Raturi, Jailal Ablack, Ping Wee, Prakash Bhandari, Douglas W. Brown, Maryam Hejazi, Nichole McMullen, Liliya Grin, Hector Vega, Henry Garcia, Natasha Govindasamy, Jitendra Kumar, Paola Solis Ares, Chandra McAllister, Katia Carmine-Simmen, Perrin H. Beatty, Adam Nelson, Eric S. Pringle, Thornton Thompson, Manoj Parmar, Jennifer Gyoba, Hong Jiang, Brent Johnston, Craig McCormick, Mary Foley, Magen Ellen Francis, Brian Abel, Alyson Kelvin, Roy Duncan and John D. Lewis
Entos Pharmaceuticals, OncoSenX, Entos Pharmaceuticals, Entos Pharmaceuticals, University of Alberta - Department of Oncology, University of Alberta - Department of Oncology, Dalhousie University - Department of Microbiology & Immunology, Entos Pharmaceuticals, Entos Pharmaceuticals, Oisin Biotechnologies, Entos Pharmaceuticals, Entos Pharmaceuticals, Entos Pharmaceuticals, Entos Pharmaceuticals, University of Alberta - Department of Oncology, Entos Pharmaceuticals, Dalhousie University - Department of Microbiology & Immunology, Dalhousie University - Department of Microbiology & Immunology, Aegis Life, Entos Pharmaceuticals, Entos Pharmaceuticals, Aegis Life, Dalhousie University - Department of Microbiology & Immunology, Dalhousie University - Department of Microbiology & Immunology, Dalhousie University - Department of Microbiology & Immunology, University of Saskatchewan - Vaccine and Infectious Disease Organization, Aegis Life, University of Saskatchewan - Vaccine and Infectious Disease Organization, Dalhousie University - Department of Microbiology & Immunology and University of Alberta - Department of Oncology
Downloads 110 (539,090)

Abstract:

Loading...

CD8+ T cells, cytotoxic T lymphocytes, FAST protein, genetic adjuvants, neutralizing antibodies, plasmid DNA vaccine, proteolipid vehicle, PLV, SARS-CoV-2, Spike protein